Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
05.06.2023 - BOSTON, June 05, 2023 (GLOBE NEWSWIRE) - Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today ...
Source: wallstreet-online.de